Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NASDAQ: CRBP · Real-Time Price · USD

7.56

0.00 (0.00%)

At close: Jun 8, 2026, 4:00 PM EDT

7.45

-0.11 (-1.48%)

Pre-market: Jun 9, 2026, 4:48 AM EDT

CRBP Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	25.66	28.49	17.2	13.72	17	25.01
Short-Term Investments	112.56	134.78	131.86	7.18	42.19	72.64
Cash & Short-Term Investments	138.22	163.27	149.06	20.91	59.2	97.65
Cash Growth	4.09%	9.53%	613.01%	-64.68%	-39.38%	14.30%
Other Current Assets	5.35	3.69	3.91	2.64	0.98	2.56
Total Current Assets	143.57	166.95	152.98	23.55	60.18	100.21
Net Property, Plant & Equipment	0.91	1.24	2.52	4.04	5.5	7
Other Long-Term Assets	-	-	0.39	0.69	0.63	0.52
Total Assets	144.48	168.2	155.88	28.27	66.31	107.73
Accounts Payable	0.44	2.22	4.79	3.18	2.17	1.78
Accrued Expenses	16.5	16.84	5.43	11.03	6	10.09
Short-Term Debt	-	-	-	16.21	0.35	0.77
Current Portion of Long-Term Debt	-	-	-	-	2.8	3.09
Current Portion of Leases	1.21	1.63	1.61	1.44	1.28	1.14
Other Current Liabilities	-	-	-	0.04	0.04	0.13
Total Current Liabilities	18.14	20.69	11.82	31.89	12.64	17.01
Long-Term Debt	-	-	-	-	15.98	15.64
Long-Term Leases	-	-	1.63	3.24	4.68	5.96
Other Long-Term Liabilities	-	-	-	0.04	0.02	0.02
Total Long-Term Liabilities	-	-	1.63	3.28	20.68	21.61
Total Liabilities	18.14	20.69	13.45	35.18	33.32	38.62
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	704.9	702.98	619.29	429.78	425.2	418.9
Accumulated Other Comprehensive Income	-0.16	-0.05	0.04	-0	-0.13	-0.06
Retained Earnings	-578.4	-555.43	-476.89	-436.68	-392.08	-349.73
Shareholders' Equity	126.34	147.5	142.43	-6.91	32.99	69.11
Total Liabilities & Equity	144.48	168.2	155.88	28.27	66.31	107.73
Total Debt	1.21	1.63	3.24	20.89	25.09	26.59
Net Cash (Debt)	137.01	161.64	145.82	0.02	34.11	71.06
Net Cash Growth	-15.23%	10.84%	694295.24%	-99.94%	-52.00%	21.26%
Net Cash Per Share	0.04	12.14	13.36	0.01	8.18	17.35
Book Value	126.34	147.5	142.43	-6.91	32.99	69.11
Book Value Per Share	0.04	11.08	13.05	-1.60	7.91	16.88
Tangible Book Value	126.34	147.5	142.43	-6.91	32.99	69.11
Tangible Book Value Per Share	0.04	11.08	13.05	-1.60	7.91	16.88

SEC Filings: 10-K · 10-Q